Mechanism underlying linezolid-induced peripheral neuropathy in multidrug-resistant tuberculosis
Multidrug-resistant tuberculosis (MDR-TB) remains a main global health concern as there is no comprehensive therapeutic intervention yet and numerous adverse effects follow the therapeutic process. In recent years, linezolid has been frequently used for treating MDR-TB. However, peripheral neuropath...
Saved in:
Main Authors: | Yuan Yuan (Author), Jinmeng Li (Author), Yanhong Chen (Author), Qingshan Cai (Author), Yingying Xu (Author), Luting Lin (Author), Yazhen Lang (Author), Suhang Guo (Author), Ruoying Zhang (Author), Xinjun Cai (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis
by: Haoyue Zhang, et al.
Published: (2023) -
A Transcriptomic Biomarker Predicting Linezolid-Associated Neuropathy During Treatment of Drug-Resistant Tuberculosis
by: Nika Zielinski, et al.
Published: (2024) -
Linezolid resistance in multidrug-resistant mycobacterium tuberculosis: A systematic review and meta-analysis
by: Taher Azimi, et al.
Published: (2022) -
Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India
by: Juan Eduardo Resendiz-Galvan, et al.
Published: (2023) -
Peripheral Neuropathy
Published: (2014)